SAN DIEGO, Nov. 27, 2024 /PRNewswire/ -- Robbins LLP reminds investors that a class action (Case No. 24-cv-02221) was filed on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences Corporation (NYSE: EW) securities between February 6, 2024 and July 24, 2024. Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.For more information, submit ...